[e-drug] Revisiting Stability & Storage Specifications of Oxytocin Injection: A Literature Review

E-DRUG: Revisiting Stability & Storage Specifications of Oxytocin Injection: A Literature Review
-------------------------------------------------------------------------------------------

Oxytocin is used to manage postpartum haemorrhage. It is effective in preventing maternal deaths, but significant challenges limit access to oxytocin, particularly for women in developing countries.

Revisiting the Stability and Storage Specifications of Oxytocin Injection: A Literature Review
<https://www.usp-pqm.org/sites/default/files/pqms/article/stability_and_storage-oxytocin_may2018.pdf&gt;

is a new publication from the Promoting the Quality of Medicines program, which is financed by the U.S. Agency for International Development and implemented by the U.S. Pharmacopeia. This document explores the effect of various factors that compromise the quality of oxytocin injection available in low- and middle-income countries. The review starts with a basic introduction to oxytocin as an active pharmaceutical ingredient and as an injection formulation, followed by a compilation of research studies to establish its solution-state stability.

Download Revisiting the Stability and Storage Specifications of Oxytocin Injection: A Literature Review at
https://www.usp-pqm.org/sites/default/files/pqms/article/stability_and_storage-oxytocin_may2018.pdf.

Paul Crustal
USP
Paul Crystal <paul.crystal@USP.org>